Cytek Biosciences CTKB
NASDAQ CTKB
$4.68 +0.06 (+1.19%)
As of: Sep 9, 2026 · 1:49 PM EDT

Cytek Biosciences (CTKB) Operating Margin Growth (1y) (2021 - 2026)

Analysis

Cytek Biosciences (CTKB) Operating Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 224.41 Bn 220.35 Bn 8.34 Bn 50.00
2 Danaher 144.30 Bn 139.96 Bn 3.61 Bn 519.00
3 Agilent Technologies 40.92 Bn 39.16 Bn 1.04 Bn 293.00
4 Illumina 31.43 Bn 30.26 Bn 770.00 Mn 93.00
5 Revvity 13.85 Bn 12.82 Bn 416.87 Mn -36.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 3,065.00
7 Bio-Rad Laboratories 10.07 Bn 8.46 Bn 345.80 Mn -68.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -77.00
9 10x Genomics 8.66 Bn 8.11 Bn 112.50 Mn -3,037.00
10 Cytek Biosciences 604.58 Mn 530.73 Mn 28.34 Mn -38.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.00
Mar 31, 2026 -571.00
Dec 31, 2025 -1,420.00
Sep 30, 2025 -933.00
Jun 30, 2025 -501.00
Mar 31, 2025 -1,219.00
Dec 31, 2024 543.00
Sep 30, 2024 513.00
Jun 30, 2024 8.00
Mar 31, 2024 886.00
Dec 31, 2023 -41.00
Sep 30, 2023 -1,673.00
Jun 30, 2023 -1,615.00
Mar 31, 2023 -2,607.00
Dec 31, 2022 -321.00
Sep 30, 2022 -507.00
Jun 30, 2022 -1,475.00
Mar 31, 2022 -1,139.00
Dec 31, 2021 -2,234.00
Sep 30, 2021 -1,831.00